JAMDA
Volume 7, Issue 3, Supplement , Pages S39-S44, March 2006

Inter-Facility Transfer of Patient Information Before and After HIPAA Privacy Measures

Presented in part at the American Geriatrics Society national meeting, Las Vegas, NV, May 2004.

  • Kenneth S. Boockvar, MD

      Affiliations

    • Geriatric Research, Education, and Clinical Center, Bronx Veterans Affairs Medical Center, Bronx, NY
    • Department of Geriatrics and Adult Development, Mount Sinai School of Medicine, New York, NY
    • The Jewish Home and Hospital Lifecare System, New York, NY
    • Corresponding Author InformationAddress correspondence to Kenneth Boockvar, MD, Bronx Veterans Affairs Medical Center, 130 W. Kingsbridge Road, Rm 4A-17, Bronx, NY 10468
  • ,
  • Bella Fridman, MD

      Affiliations

    • Department of Geriatrics and Adult Development, Mount Sinai School of Medicine, New York, NY
    • The Jewish Home and Hospital Lifecare System, New York, NY

Objectives

The study objectives were (1) to test whether interfacility communication of health information at the time of patient transfer changed as a result of implementation of US privacy protection measures (HIPAA) in April 2003, and (2) to examine patient, transfer, and illness characteristics correlated with interfacility transfer document completion.

Design

Observational study.

Participants and Setting

Individuals transferred between a 514-bed urban nursing home and a 1171-bed academic hospital in New York City.

Measurements

Research staff reviewed medical records of patients transferred both ways between nursing home and hospital, examining interfacility transfer documents for 12 items important for continuity of care. Transfer document completeness equaled the percentage of items recorded and legible in transfer documents. Transfers were classified by direction (nursing home-to-hospital [NH-to-H] or hospital-to-nursing home [H-to-NH]), urgency (urgent or not), timing (weekday 9 am to 6 pm or other), and by whether they occurred before 12 am April 14, 2003 (pre-HIPAA), or after (post-HIPAA).

Results

Seventy-eight nursing home residents experienced 100 hospital admissions. NH-to-H transfer documents were more complete than H-to-NH documents (86.7% vs 69.0%; P = .002). There were no significant differences between content of transfer documents between pre- and post-HIPAA transfers in either direction of transfer, with and without controlling for patient and illness characteristics. Older age, female gender, dementia diagnosis, shorter duration of nursing home residence, and off-hours hospital transfer were associated with less complete NH-to-H transfer documents, and shorter hospital length of stay was associated with less complete H-to-NH transfer documents.

Conclusion

There was no change in written health information communicated during patient transfer between an urban nursing home and an academic hospital before and after HIPAA privacy protection measures were implemented. This suggests that the rule’s intent to not restrict the sharing of information needed to treat patients is being followed by providers at these sites in the situation of interfacility patient transfer.

Keywords:  Hospitalization , communication , Health Insurance Portability and Accountability Act

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Dr. Boockvar is the recipient of a research award cosponsored by Pfizer, Inc, the American Geriatrics Society, and the Foundation for Health in Aging, and a research award cosponsored by Pfizer, Inc, and the American Medical Directors Association Foundation.Supported by The New York State Department of Health (Dementia Grant Program). Dr. Boockvar is a recipient of a Junior Faculty Scholarship for Research on Health Outcomes in Geriatrics from Pfizer/American Geriatrics Society/Foundation for Health in Aging, a Long-Term Care Quality Improvement Award from Pfizer/American Medical Directors Association Foundation, and a Research Career Development Award from Department of Veterans Affairs Health Services Research and Development Service.

PII: S1525-8610(05)00688-2

doi:10.1016/j.jamda.2005.12.014

JAMDA
Volume 7, Issue 3, Supplement , Pages S39-S44, March 2006